Normunity appoints industry leader Debanjan Ray to Board of Directors
BOSTON & WEST HAVEN, Conn.--(BUSINESS WIRE)--Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv...
United States Massachusetts Institute Of Technology Rachel Humphrey Debanjan Ray Normunity Inc University Of Pennsylvania
Source: pharmiweb.com